In the context of the health crisis linked to the spread of the COVID 19 virus, the Servier group’s main concern is the health and safety of the Group’s employees, which is an absolute priority. We are also aware of our responsibility, as a health care company, to ensure that our medicines remain available to patients.
Since January, a Group crisis unit has been dedicated to monitoring the situation and following its evolution. All our decisions respect the directives of local health authorities and the governments of each country where the Group operates.
Given the situation in the Nordic countries and in accordance with the directives of the national health authorities, Servier Southern Africa has in particular decided to suspend the visits to healthcare units and meetings with healthcare professionals and to implement home office for every employee until the situation improves.
This choice stems from the need both to protect the health of employees and the people who have contacts with them and to actively contribute to contain as much as possible the potential spread of the virus.
We also believe that this is a dutiful and responsible act in respect of health personnel engaged in the containment of the infection and in the management of any emergencies.
Specific measures have also been taken to continue the activities at our production and R&D sites, while respecting health and safety conditions for employees whose presence is essential to the continuity of activities.
All these measures are in force until further notice. They may be adapted as the situation develops and in accordance with the directives of the authorities.
Our Group is thus fully mobilized to participate in the fight against the spread of the virus, while maintaining, as much as possible, the production and availability of our medicines for patients.
